Articles by Jordana Jampel
There are both positives and negatives associated with either testing method.
The researchers focused on white matter microstructures in the relationship between REM-OSA and cognition decline.
The nanoparticle design delivers mRNA to resting CD4+ T cells, enabling HIV reactivation without toxicity.
Most patients switching from modafinils to solriamfetol preferred it, citing better effects; others reverted due to side effe
The drug was well-tolerated and adverse reactions were minimal to moderate in severity.
The researchers considered age, sex, and race/ethnicity to determine differing pathophysiologies.
Forty-seven genes were linked to patient survival.
Lower education level was linked to reduced access to mutational testing and clinical trials.
The prospective case series demonstrates the efficacy of the combination in second- and later-line treatment.
Targeted therapies directed toward tumor genotype should be considered in addition to standard-of-care regimens.
This was an unexpected finding because mature TLS are typically rare in poorly immunogenic HPV-negative HNSCC.
Tumor mutations were even detected in early-stage disease.
The findings reaffirm concurrent chemoradiotherapy as a cornerstone of treatment.
Patient-derived cells have the potential to enhance drug screening tools and improve patient outcomes.
Researchers identified the pathologic and clinical characteristics of patients who experience disease relapse.
The drug significantly reduced the annual rate of moderate or severe exacerbations in eosinophilic phenotypes.
Treatment with the drug demonstrated lesion and pain control in moderate to severe disease.
Symptomatic benefits of treatment on the severity of pustules, erythema, and scaling were observed.
At-home administration was safe, effective, and had higher participant satisfaction.
The developed scale strengthens the investigation of global irritable bowel disease epidemiology.
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.